FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate (Atripla) Tablets
Status: Discontinuation
»Therapeutic Categories: Antiviral

Gilead Sciences, LLC (New 02/04/2021)

Company Contact Information:

Presentation Posting Date Related Information
600 mg; 200 mg; 300 mg (NDC 15584-0101-1) 02/04/2021 Date of permanent discontinuation of manufacture is July 2021. Product expected to be available until December 2021.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English